|

Carboplatin/Cisplatin Clinical Trials

4 actively recruiting trials

▲ +2 trials since June 2026

Pipeline

Phase 1: 1Phase 2: 2Phase 1/2: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
  • Second Affiliated Hospital, School of Medicine, Zhejiang University1
  • Nanfang Hospital, Southern Medical University1
  • HC Biopharma Inc.1

Indications

  • Cancer4
  • Lung Cancer3
  • Extensive Disease Small Cell Lung Cancer1
  • Extensive Stage Lung Small Cell Cancer1
  • Advanced Solid Tumor Cancer1

Other4 trials

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
Phase 1
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Phase 1/2
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.